Reuters -- U.S. antitrust enforcers firmly denied on Thursday sharing any confidential information while investigating a deal between Cephalon and Watson Pharmaceuticals to determine if it broke antitrust law.
Reuters -- U.S. antitrust enforcers firmly denied on Thursday sharing any confidential information while investigating a deal between Cephalon and Watson Pharmaceuticals to determine if it broke antitrust law.